JUSTIN CAMPBELL: Open Payments
NPI 1619574738 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,201 in 110 payments from 23 companies in 2025. Trend: 2023 $1,776 · 2024 $1,727 · 2025 $2,201
Food & beverage: $2,201
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 33 | $501 |
| HARMONY BIOSCIENCES LLC | 8 | $233 |
| AstraZeneca Pharmaceuticals LP | 7 | $189 |
| Merck Sharp & Dohme LLC | 9 | $180 |
| Electromed, Inc. | 8 | $117 |
| Grifols USA, LLC | 4 | $115 |
| Pulmonx Corporation | 4 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $92 |
| Genentech USA, Inc. | 4 | $87 |
| JAZZ PHARMACEUTICALS INC. | 3 | $75 |
Products named: NUCALA, WAKIX, TRELEGY ELLIPTA, FASENRA, DUPIXENT, SMARTVEST, Prolastin-C Liquid, ZERBAXA.
Industry payments across MS — which companies pay providers there.
